Fighting for patient affordability doesn’t necessarily require a scapegoat.
In Search of the ‘Bad Guy’
Related Posts
Artificial Intelligence May Accelerate Time to Determine Response to Treatment
Image credit: photon_photo | stock.adobe.com. Researchers are beginning to realize the potential of artificial intelligence to predict the safety and…
Establishing Additional Transparency
In a video interview with Pharma Commerce, LeAnn Boyd, PharmD, Liviniti’s founder and CEO, discusses the deeper, systemic issues behind…
GLP-1 Drugs Reshape Reimbursement and Coverage Models
In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current…